Top 5 Drug Type | Count |
---|---|
Small molecule drug | 33 |
Non-degrading molecular glue | 1 |
Monoclonal antibody | 1 |
Target |
Mechanism 50S subunit inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date20 Oct 2023 |
Target |
Mechanism IL-17RA antagonists |
Active Org. |
Originator Org. |
Active Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. Japan |
First Approval Date04 Jul 2016 |
Mechanism DNA-directed DNA polymerase inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. United States |
First Approval Date31 Jul 2009 |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Griseofulvin ( Tubulin ) | Tinea corporis More | Approved |
Luliconazole ( fungal CYP51A1 ) | Tinea Manus More | Approved |
Imiquimod ( TLR7 ) | Actinic Keratosis More | Approved |
Chlordiazepoxide Hydrochloride/Clidinium Bromide ( GABAA receptor ) | Enterocolitis More | Approved |
Acyclovir ( DNA-directed DNA polymerase ) | Herpes Genitalis More | Approved |